| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 1.50e-06 | 99 | 168 | 8 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 1.61e-06 | 100 | 168 | 8 | GO:0045103 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 3.38e-05 | 75 | 168 | 6 | GO:0045109 | |
| Domain | ARM-type_fold | PDS5B WAPL COPB1 USP9X CIP2A LRRK2 RICTOR USP9Y INF2 INTS4 RIC8A NUP188 HEATR3 XPO7 | 2.27e-06 | 339 | 167 | 14 | IPR016024 |
| Domain | Keratin_I | 2.49e-06 | 44 | 167 | 6 | IPR002957 | |
| Domain | Prefoldin | 3.64e-06 | 72 | 167 | 7 | IPR009053 | |
| Domain | Intermediate_filament_CS | 2.08e-05 | 63 | 167 | 6 | IPR018039 | |
| Domain | ARM-like | PDS5B COPB1 USP9X CIP2A LRRK2 RICTOR USP9Y INTS4 RIC8A HEATR3 XPO7 | 3.24e-05 | 270 | 167 | 11 | IPR011989 |
| Domain | Filament | 4.14e-05 | 71 | 167 | 6 | SM01391 | |
| Domain | IF | 4.48e-05 | 72 | 167 | 6 | PS00226 | |
| Domain | Filament | 4.85e-05 | 73 | 167 | 6 | PF00038 | |
| Domain | IF | 6.09e-05 | 76 | 167 | 6 | IPR001664 | |
| Domain | CAPS | 7.95e-05 | 2 | 167 | 2 | IPR033227 | |
| Domain | ARHGEF5_35 | 7.95e-05 | 2 | 167 | 2 | PF15441 | |
| Domain | ARHGEF5/35_N | 7.95e-05 | 2 | 167 | 2 | IPR029212 | |
| Domain | TPR_REGION | 1.21e-04 | 165 | 167 | 8 | PS50293 | |
| Domain | TPR | 1.21e-04 | 165 | 167 | 8 | PS50005 | |
| Domain | TPR | 1.61e-04 | 129 | 167 | 7 | SM00028 | |
| Domain | - | 1.78e-04 | 222 | 167 | 9 | 1.25.10.10 | |
| Domain | TPR_repeat | 1.95e-04 | 133 | 167 | 7 | IPR019734 | |
| Domain | PH | ARHGEF5 RALGPS2 SPTBN4 ARHGEF40 PLEKHM2 CADPS PLEKHG3 PLEKHH2 CADPS2 ARHGEF26 | 2.06e-04 | 278 | 167 | 10 | SM00233 |
| Domain | PH_DOMAIN | ARHGEF5 RALGPS2 SPTBN4 ARHGEF40 PLEKHM2 CADPS PLEKHG3 PLEKHH2 CADPS2 ARHGEF26 | 2.13e-04 | 279 | 167 | 10 | PS50003 |
| Domain | PH_domain | ARHGEF5 RALGPS2 SPTBN4 ARHGEF40 PLEKHM2 CADPS PLEKHG3 PLEKHH2 CADPS2 ARHGEF26 | 2.19e-04 | 280 | 167 | 10 | IPR001849 |
| Domain | PH | ARHGEF5 RALGPS2 SPTBN4 PLEKHM2 CADPS PLEKHG3 PLEKHH2 CADPS2 ARHGEF26 | 2.24e-04 | 229 | 167 | 9 | PF00169 |
| Domain | Serum_albumin/AFP/Afamin | 2.37e-04 | 3 | 167 | 2 | IPR021177 | |
| Domain | SUZ | 2.37e-04 | 3 | 167 | 2 | PF12752 | |
| Domain | DH_1 | 2.49e-04 | 63 | 167 | 5 | PS00741 | |
| Domain | RhoGEF | 4.08e-04 | 70 | 167 | 5 | PF00621 | |
| Domain | DH_2 | 4.08e-04 | 70 | 167 | 5 | PS50010 | |
| Domain | - | 4.35e-04 | 71 | 167 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 4.35e-04 | 71 | 167 | 5 | IPR000219 | |
| Domain | ALBUMIN | 4.71e-04 | 4 | 167 | 2 | SM00103 | |
| Domain | Serum_albumin_N | 4.71e-04 | 4 | 167 | 2 | IPR014760 | |
| Domain | SUZ | 4.71e-04 | 4 | 167 | 2 | IPR024771 | |
| Domain | Serum_albumin_CS | 4.71e-04 | 4 | 167 | 2 | IPR020857 | |
| Domain | ALBUMIN_2 | 4.71e-04 | 4 | 167 | 2 | PS51438 | |
| Domain | SUZ | 4.71e-04 | 4 | 167 | 2 | PS51673 | |
| Domain | ALBUMIN_1 | 4.71e-04 | 4 | 167 | 2 | PS00212 | |
| Domain | Serum_albumin | 4.71e-04 | 4 | 167 | 2 | PF00273 | |
| Domain | Serum_albumin-like | 7.81e-04 | 5 | 167 | 2 | IPR020858 | |
| Domain | Na/ntran_symport_orphan | 7.81e-04 | 5 | 167 | 2 | IPR002438 | |
| Domain | DUF1041 | 7.81e-04 | 5 | 167 | 2 | SM01145 | |
| Domain | Spectrin | 1.09e-03 | 23 | 167 | 3 | PF00435 | |
| Domain | ACTININ_2 | 1.09e-03 | 23 | 167 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.09e-03 | 23 | 167 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.09e-03 | 23 | 167 | 3 | IPR001589 | |
| Domain | HNOB_dom_associated | 1.16e-03 | 6 | 167 | 2 | IPR011645 | |
| Domain | FAD-bd | 1.16e-03 | 6 | 167 | 2 | IPR002938 | |
| Domain | FAD_binding_3 | 1.16e-03 | 6 | 167 | 2 | PF01494 | |
| Domain | HNOBA | 1.16e-03 | 6 | 167 | 2 | PF07701 | |
| Domain | ALB/AFP/VDB | 1.16e-03 | 6 | 167 | 2 | IPR000264 | |
| Domain | cEGF | 1.57e-03 | 26 | 167 | 3 | PF12662 | |
| Domain | cEGF | 1.57e-03 | 26 | 167 | 3 | IPR026823 | |
| Domain | PH_dom-like | ARHGEF5 RALGPS2 MYO1B SPTBN4 ARHGEF40 PLEKHM2 CADPS PLEKHG3 PLEKHH2 CADPS2 ARHGEF26 | 1.60e-03 | 426 | 167 | 11 | IPR011993 |
| Domain | Munc13_1 | 1.62e-03 | 7 | 167 | 2 | IPR014770 | |
| Domain | MHD1 | 1.62e-03 | 7 | 167 | 2 | PS51258 | |
| Domain | DUF1041 | 1.62e-03 | 7 | 167 | 2 | PF06292 | |
| Domain | CAPS_dom | 1.62e-03 | 7 | 167 | 2 | IPR010439 | |
| Domain | Spectrin_repeat | 2.16e-03 | 29 | 167 | 3 | IPR002017 | |
| Domain | TPR-contain_dom | 2.32e-03 | 150 | 167 | 6 | IPR013026 | |
| Domain | - | 2.64e-03 | 207 | 167 | 7 | 1.25.40.10 | |
| Domain | CH | 2.73e-03 | 65 | 167 | 4 | SM00033 | |
| Domain | MYTH4 | 2.75e-03 | 9 | 167 | 2 | PS51016 | |
| Domain | R3H | 2.75e-03 | 9 | 167 | 2 | SM00393 | |
| Domain | MyTH4 | 2.75e-03 | 9 | 167 | 2 | SM00139 | |
| Domain | MyTH4_dom | 2.75e-03 | 9 | 167 | 2 | IPR000857 | |
| Domain | MyTH4 | 2.75e-03 | 9 | 167 | 2 | PF00784 | |
| Domain | - | ARHGEF5 RALGPS2 SPTBN4 ARHGEF40 PLEKHM2 CADPS PLEKHG3 PLEKHH2 CADPS2 ARHGEF26 | 2.78e-03 | 391 | 167 | 10 | 2.30.29.30 |
| Domain | SPEC | 2.88e-03 | 32 | 167 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.88e-03 | 32 | 167 | 3 | IPR018159 | |
| Domain | RhoGEF | 3.22e-03 | 68 | 167 | 4 | SM00325 | |
| Domain | TPR_7 | 3.41e-03 | 10 | 167 | 2 | PF13176 | |
| Domain | CH | 3.57e-03 | 70 | 167 | 4 | PF00307 | |
| Domain | - | 3.72e-03 | 35 | 167 | 3 | 3.20.20.80 | |
| Domain | - | 3.76e-03 | 71 | 167 | 4 | 1.10.418.10 | |
| Domain | R3H | 4.15e-03 | 11 | 167 | 2 | PS51061 | |
| Domain | R3H | 4.15e-03 | 11 | 167 | 2 | PF01424 | |
| Domain | - | 4.15e-03 | 11 | 167 | 2 | 3.30.1370.50 | |
| Domain | R3H_dom | 4.15e-03 | 11 | 167 | 2 | IPR001374 | |
| Domain | CH | 4.16e-03 | 73 | 167 | 4 | PS50021 | |
| Domain | CH-domain | 4.58e-03 | 75 | 167 | 4 | IPR001715 | |
| Domain | Glyco_hydro_catalytic_dom | 4.71e-03 | 38 | 167 | 3 | IPR013781 | |
| Domain | EGF_CA | 4.82e-03 | 122 | 167 | 5 | SM00179 | |
| Domain | TPR-like_helical_dom | 5.05e-03 | 233 | 167 | 7 | IPR011990 | |
| Domain | EGF-like_Ca-bd_dom | 5.16e-03 | 124 | 167 | 5 | IPR001881 | |
| Domain | EGF_CA | 7.42e-03 | 86 | 167 | 4 | PF07645 | |
| Domain | TPR_1 | 8.68e-03 | 90 | 167 | 4 | IPR001440 | |
| Domain | TPR_1 | 8.68e-03 | 90 | 167 | 4 | PF00515 | |
| Pathway | REACTOME_COHESIN_LOADING_ONTO_CHROMATIN | 6.74e-05 | 10 | 119 | 3 | M27178 | |
| Pathway | REACTOME_COHESIN_LOADING_ONTO_CHROMATIN | 6.74e-05 | 10 | 119 | 3 | MM14892 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 9.22e-05 | 87 | 119 | 6 | MM15351 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 1.37e-04 | 59 | 119 | 5 | M11215 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 1.58e-04 | 13 | 119 | 3 | MM15363 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 1.58e-04 | 13 | 119 | 3 | M27661 | |
| Pubmed | STARD13 PDS5B FAM184B KRT10 STIM2 TTC24 KRT13 KRT15 KRT17 SYNE1 KIF21A SIPA1L3 FBF1 DNAH2 SRP72 MYO1B SPG11 MYNN PFKM RRBP1 PALB2 TASOR2 SPTBN4 USP8 DST SNX25 PHF14 BSN CADPS2 SFN | 2.56e-11 | 1442 | 172 | 30 | 35575683 | |
| Pubmed | KRT9 KRT10 STIM2 KRT17 EFCAB6 TTC28 COPB1 CCDC30 SEC24A LRRK2 MUC16 RICTOR TASOR2 BLM DST WDR11 PLEKHM2 CDK5RAP2 ALB XPO7 | 2.10e-09 | 777 | 172 | 20 | 35844135 | |
| Pubmed | 8.05e-09 | 15 | 172 | 5 | 10087197 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | GNL3L VEZT SDCCAG8 SIPA1L3 TUSC3 ARHGEF38 VPS54 ARHGAP39 RRBP1 TASOR2 SPTBN4 POGLUT1 WDR11 GUCY1A1 INF2 PTPRR MICAL2 PLEKHG3 TBCK PHF14 TNFRSF19 IGSF9B PATJ POLK ARHGEF26 XPO7 | 2.33e-08 | 1489 | 172 | 26 | 28611215 |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | CACNA1B COPB1 LRRK2 FYCO1 PFKM MYO5C TAF6L CDK5RAP2 CARD11 BSN | 9.72e-08 | 208 | 172 | 10 | 33230847 |
| Pubmed | KRT9 KRT10 KRT13 KRT15 KRT17 KRT32 USP9X USP9Y AGO1 STON2 SFN | 1.01e-07 | 266 | 172 | 11 | 19380743 | |
| Pubmed | WAPL TTC28 COPB1 USP9X SYNE1 KIF21A SIPA1L3 EFEMP2 MYNN MSH3 VPS54 RRBP1 USP9Y STAT6 SPTBN4 USP8 DST CADPS MICAL2 FBXO7 R3HDM1 CADPS2 CABIN1 | 1.06e-07 | 1285 | 172 | 23 | 35914814 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | STARD13 PDS5B WAPL ANKFY1 GNL3L COPB1 AHCTF1 KIF21A MYO1B RICTOR MSH3 PFKM RRBP1 MTPAP BLM ARHGEF40 DST WDR11 INF2 MICAL2 PLEKHG3 CHTF18 RIC8A | 2.62e-07 | 1353 | 172 | 23 | 29467282 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT9 KRT10 KRT13 GNL3L KRT15 KRT17 AHCTF1 SIPA1L3 WDR18 SRP72 MYO1B RRBP1 MTPAP TASOR2 TXLNA DST WDR11 PLEKHG3 STON2 ALB PATJ SFN | 3.00e-07 | 1257 | 172 | 22 | 36526897 |
| Pubmed | ANKFY1 USP9X SYNE1 KIF21A SIPA1L3 MCC WDR18 FYCO1 ARHGAP39 SPTBN4 TXLNA DST AGO1 STON2 CDK5RAP2 BSN CABIN1 ARHGEF26 GOLGA1 | 3.47e-07 | 963 | 172 | 19 | 28671696 | |
| Pubmed | 3.95e-07 | 57 | 172 | 6 | 31862882 | ||
| Pubmed | STIM2 TTC28 COPB1 USP9X CIP2A SEC24A AHCTF1 SRP72 MYO1B RICTOR ARHGAP39 RRBP1 DST PATJ ARHGEF26 NOTCH1 | 5.31e-07 | 708 | 172 | 16 | 39231216 | |
| Pubmed | TTC28 KRT32 USP9X CIP2A SIPA1L3 MYO1B E2F4 MSH3 RRBP1 PALB2 DST MICAL2 RIC8A NUP188 XPO7 | 6.92e-07 | 634 | 172 | 15 | 34591612 | |
| Pubmed | 7.21e-07 | 63 | 172 | 6 | 16831889 | ||
| Pubmed | 1.18e-06 | 5 | 172 | 3 | 11785984 | ||
| Pubmed | beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. | 1.31e-06 | 17 | 172 | 4 | 11371349 | |
| Pubmed | DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | 3.16e-06 | 238 | 172 | 9 | 35864588 | |
| Pubmed | 4.06e-06 | 130 | 172 | 7 | 12421765 | ||
| Pubmed | 4.10e-06 | 7 | 172 | 3 | 16818453 | ||
| Pubmed | WAPL GNL3L TTC28 ARHGEF5 SRP72 RICTOR RRBP1 TXLNA ARHGEF40 DST WDR11 CHTF18 PATJ HEATR3 | 4.86e-06 | 650 | 172 | 14 | 38777146 | |
| Pubmed | E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis. | 5.21e-06 | 135 | 172 | 7 | 29859926 | |
| Pubmed | TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity. | 6.31e-06 | 91 | 172 | 6 | 34445801 | |
| Pubmed | 14-3-3σ controls corneal epithelium homeostasis and wound healing. | 6.54e-06 | 8 | 172 | 3 | 21228373 | |
| Pubmed | STIM2 THSD7A CIP2A SIPA1L3 PER1 RICTOR ARHGAP39 FAT2 WDR11 PLEKHG3 PHF14 PLEKHH2 | 7.03e-06 | 493 | 172 | 12 | 15368895 | |
| Pubmed | KANSL1L KRT10 ANKFY1 KRT17 SYNE1 SRP72 DST CLIC5 AGL INTS4 CDK5RAP2 PYGM | 7.63e-06 | 497 | 172 | 12 | 23414517 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | PDS5B CWF19L2 KRT9 KRT10 SYNE1 BCKDK WDR18 SRP72 MYO1B ARHGAP39 USP9Y ZSCAN29 BLM NWD2 DST AGO1 INTS4 ALB | 7.73e-06 | 1082 | 172 | 18 | 38697112 |
| Pubmed | microRNA-184 Induces a Commitment Switch to Epidermal Differentiation. | 9.77e-06 | 9 | 172 | 3 | 29198823 | |
| Pubmed | Sox21 Regulates Anapc10 Expression and Determines the Fate of Ectodermal Organ. | 1.08e-05 | 28 | 172 | 4 | 32674056 | |
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 1.22e-05 | 102 | 172 | 6 | 15778465 | |
| Pubmed | 1.22e-05 | 60 | 172 | 5 | 31220272 | ||
| Pubmed | 1.31e-05 | 284 | 172 | 9 | 29459677 | ||
| Pubmed | Spatiotemporal expression pattern of keratins in skin of AP-2alpha-deficient mice. | 1.39e-05 | 10 | 172 | 3 | 10571739 | |
| Pubmed | TTC28 USP9X SIPA1L3 FBF1 RALGPS2 RICTOR USP8 DST R3HDM1 PATJ NOTCH1 | 1.51e-05 | 446 | 172 | 11 | 24255178 | |
| Pubmed | 1.76e-05 | 225 | 172 | 8 | 12168954 | ||
| Pubmed | 1.81e-05 | 65 | 172 | 5 | 29795372 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | PDS5B WAPL COPB1 SYNE1 AHCTF1 SIPA1L3 PER1 MCC WDR18 MAU2 RRBP1 MTPAP TASOR2 BLM INF2 CDK5RAP2 PYGM NUP188 | 1.85e-05 | 1155 | 172 | 18 | 20360068 |
| Pubmed | 1.90e-05 | 11 | 172 | 3 | 16085486 | ||
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | 1.91e-05 | 298 | 172 | 9 | 32353859 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | KIF21A ROR1 DNAH2 MTPAP TAF6L LOXHD1 DST AGL ATAD2B PHF14 IGSF9B ALB NUP188 HEATR3 | 1.95e-05 | 736 | 172 | 14 | 29676528 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | PDS5B WAPL GNL3L COPB1 VEZT USP9X CIP2A AHCTF1 DNAH2 SRP72 ARHGEF40 INF2 RIC8A NUP188 HEATR3 XPO7 | 1.97e-05 | 942 | 172 | 16 | 31073040 |
| Pubmed | 2.26e-05 | 233 | 172 | 8 | 37704626 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 18177725 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 31527799 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 34223928 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 25736868 | ||
| Pubmed | Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome. | 2.43e-05 | 2 | 172 | 2 | 12895410 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 3795040 | ||
| Pubmed | A POGLUT1 mutation causes a muscular dystrophy with reduced Notch signaling and satellite cell loss. | 2.43e-05 | 2 | 172 | 2 | 27807076 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 36781503 | ||
| Pubmed | CAPS-1 and CAPS-2 are essential synaptic vesicle priming proteins. | 2.43e-05 | 2 | 172 | 2 | 18022372 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 28883501 | ||
| Pubmed | Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder. | 2.43e-05 | 2 | 172 | 2 | 15286787 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 8922996 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 29039449 | ||
| Pubmed | Two distinct secretory vesicle-priming steps in adrenal chromaffin cells. | 2.43e-05 | 2 | 172 | 2 | 20855507 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 37344480 | ||
| Pubmed | CAPS facilitates filling of the rapidly releasable pool of large dense-core vesicles. | 2.43e-05 | 2 | 172 | 2 | 18495893 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 24247036 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 12925892 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 28299521 | ||
| Pubmed | TLR2 signaling and Th2 responses drive Tannerella forsythia-induced periodontal bone loss. | 2.43e-05 | 2 | 172 | 2 | 21632710 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 36654782 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 25719439 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 7504553 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 25480567 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 37205094 | ||
| Pubmed | A keratin cytoskeletal protein regulates protein synthesis and epithelial cell growth. | 2.43e-05 | 2 | 172 | 2 | 16710422 | |
| Pubmed | Identification of a deubiquitinating enzyme as a novel AGS3-interacting protein. | 2.43e-05 | 2 | 172 | 2 | 20305814 | |
| Pubmed | PDS5B COPB1 USP9X AHCTF1 WDR18 SRP72 MYO1B TASOR2 BLM DST ATAD2B NUP188 XPO7 | 2.44e-05 | 653 | 172 | 13 | 22586326 | |
| Pubmed | Airway basal cells show regionally distinct potential to undergo metaplastic differentiation. | 2.53e-05 | 12 | 172 | 3 | 36178196 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | HEXA KRT9 KRT10 KRT13 KRT15 KRT17 FYCO1 RRBP1 RIC8A ALB NUP188 SFN | 2.66e-05 | 564 | 172 | 12 | 21565611 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | STIM2 TTC28 ARHGEF5 SEC24A SIPA1L3 RALGPS2 RICTOR CDR2L USP8 DST PLEKHG3 TET1 R3HDM1 PATJ SFN | 2.71e-05 | 861 | 172 | 15 | 36931259 |
| Pubmed | USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia. | 3.19e-05 | 73 | 172 | 5 | 30224337 | |
| Pubmed | FNIP2 PDS5B ANKFY1 TTC28 SYNE1 USP8 PLEKHM2 CADPS R3HDM1 XPO7 | 3.84e-05 | 407 | 172 | 10 | 12693553 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | KRT13 COPB1 USP9X CIP2A AHCTF1 KIF21A MYO1B DST CADPS SPOCK3 RIC8A | 4.14e-05 | 498 | 172 | 11 | 36634849 |
| Pubmed | Mice with a targeted mutation of patched2 are viable but develop alopecia and epidermal hyperplasia. | 4.16e-05 | 14 | 172 | 3 | 16914743 | |
| Pubmed | 4.17e-05 | 411 | 172 | 10 | 36652389 | ||
| Pubmed | 4.91e-05 | 191 | 172 | 7 | 33762435 | ||
| Pubmed | Deubiquitinating enzymes: a new class of biological regulators. | 5.18e-05 | 15 | 172 | 3 | 9827704 | |
| Pubmed | Multiple roles of Notch signaling in the regulation of epidermal development. | 5.18e-05 | 15 | 172 | 3 | 18410734 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 6.08e-05 | 430 | 172 | 10 | 35044719 | |
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 6.28e-05 | 84 | 172 | 5 | 29563501 | |
| Pubmed | 6.35e-05 | 16 | 172 | 3 | 36418889 | ||
| Pubmed | 6.35e-05 | 16 | 172 | 3 | 17631878 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 6.99e-05 | 202 | 172 | 7 | 33005030 | |
| Pubmed | KRT17 VEZT USP9X CIP2A SEC24A SIPA1L3 BCKDK MYO1B RICTOR ARHGAP39 BLM WDR11 PTPRR INTS4 CDK5RAP2 NOTCH1 | 7.08e-05 | 1049 | 172 | 16 | 27880917 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 27698452 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 7535287 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 26240152 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 18768873 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 12297623 | ||
| Pubmed | Comprehensive clinical and molecular analysis of 12 families with type 1 recessive cutis laxa. | 7.27e-05 | 3 | 172 | 2 | 22829427 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 25713297 | ||
| Pubmed | Secretory vesicle priming by CAPS is independent of its SNARE-binding MUN domain. | 7.27e-05 | 3 | 172 | 2 | 25437547 | |
| Pubmed | Cellular stress induces TRB3/USP9x-dependent Notch activation in cancer. | 7.27e-05 | 3 | 172 | 2 | 27593927 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 24471966 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 12077355 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 24359035 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 12659812 | ||
| Pubmed | An Alternative Exon of CAPS2 Influences Catecholamine Loading into LDCVs of Chromaffin Cells. | 7.27e-05 | 3 | 172 | 2 | 30389842 | |
| Interaction | KCNA3 interactions | CACNA1B STIM2 TTC28 COPB1 USP9X CIP2A SEC24A AHCTF1 LRRK2 SRP72 MYO1B RICTOR FYCO1 ARHGAP39 PFKM RRBP1 MYO5C TAF6L DST CDK5RAP2 CARD11 BSN PATJ ARHGEF26 NOTCH1 | 5.14e-08 | 871 | 166 | 25 | int:KCNA3 |
| GeneFamily | Keratins, type I | 1.76e-08 | 28 | 113 | 6 | 608 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.49e-06 | 66 | 113 | 6 | 722 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | RALGPS2 SPTBN4 PLEKHM2 CADPS PLEKHG3 PLEKHH2 CADPS2 ARHGEF26 | 4.56e-05 | 206 | 113 | 8 | 682 |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 7.76e-04 | 115 | 113 | 5 | 769 | |
| GeneFamily | Fibulins | 1.06e-03 | 8 | 113 | 2 | 556 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | SYNE1 ROR1 LRRK2 ARHGEF38 MYO1B MYO5C CLIC5 MICAL2 SNX25 PATJ CADPS2 ARHGEF26 | 1.42e-11 | 194 | 171 | 12 | 53f3e49e91b1096f3226010e2de767efb490dfe4 |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | SYNE1 ROR1 LRRK2 ARHGEF38 MYO1B MYO5C CLIC5 MICAL2 SNX25 PATJ CADPS2 | 2.75e-10 | 195 | 171 | 11 | 9406866f99555198a9be311fbd65751b70f35446 |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.31e-08 | 172 | 171 | 9 | e9095c3dac66cf93d31f5f88364b565abacb1e2d | |
| ToppCell | AT1_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.96e-08 | 177 | 171 | 9 | 3128b8d04687acee1ac4190b2569d6328b98eaf3 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 4.98e-08 | 188 | 171 | 9 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 5.45e-08 | 190 | 171 | 9 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 5.97e-08 | 192 | 171 | 9 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Biopsy_IPF-Epithelial-Basal|Biopsy_IPF / Sample group, Lineage and Cell type | 8.46e-08 | 200 | 171 | 9 | 5cea84581201cee7ba8141b96e65864f4fd67113 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 8.46e-08 | 200 | 171 | 9 | 592c7c3ded409a9957cbcdc62fcc213fa8eae598 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.46e-08 | 200 | 171 | 9 | 8cfbde43c5e66269ad128aa5398b1517667d7d36 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.46e-08 | 200 | 171 | 9 | 61811380d9252f12f27b7ad4752380b52692677f | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-07 | 160 | 171 | 8 | 18ae6822915d16699beb9047baeef9b006901a35 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-07 | 160 | 171 | 8 | 830f17bad94de05612fe6d53d39e42a4b3f3e2f3 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.12e-07 | 161 | 171 | 8 | da9eecf919866a9c579d7a707a996cf335213134 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.12e-07 | 161 | 171 | 8 | d431625c32f59a6b552191f3adc5198bd16ad5cf | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.21e-07 | 170 | 171 | 8 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-07 | 182 | 171 | 8 | 678eadd57e7e830fc2bf9fd35616d3badce01705 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-07 | 182 | 171 | 8 | 8d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.85e-07 | 184 | 171 | 8 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-07 | 184 | 171 | 8 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.85e-07 | 184 | 171 | 8 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 6.09e-07 | 185 | 171 | 8 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.09e-07 | 185 | 171 | 8 | 87151ab95530e70d61328b336518df58db584acb | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 6.61e-07 | 187 | 171 | 8 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 6.61e-07 | 187 | 171 | 8 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 7.16e-07 | 189 | 171 | 8 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 7.16e-07 | 189 | 171 | 8 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.75e-07 | 191 | 171 | 8 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 8.06e-07 | 192 | 171 | 8 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-H_(AT1)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.06e-07 | 192 | 171 | 8 | 7a6dd2ae217b8f8e460d47ad128904408299458c | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.38e-07 | 193 | 171 | 8 | 7c34abdcb8839b9fb25457a79af6c5e7b9714b21 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 8.38e-07 | 193 | 171 | 8 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.72e-07 | 194 | 171 | 8 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 9.78e-07 | 197 | 171 | 8 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | 3'-Broncho-tracheal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.78e-07 | 197 | 171 | 8 | 5d33f8a6940431093e927b186fb9b630a89d8ec1 | |
| ToppCell | Epithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.02e-06 | 198 | 171 | 8 | 4235005c49fc2b29ad3a0ee6b608f0109d04f775 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-06 | 198 | 171 | 8 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-06 | 198 | 171 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-06 | 198 | 171 | 8 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-06 | 199 | 171 | 8 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | PSB-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.06e-06 | 199 | 171 | 8 | 2add64c3e4cb6384ec381f34c3f1f77e13e3f27c | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-06 | 200 | 171 | 8 | afac850d5a40de0d6f02857cf81a19443d90b1eb | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-06 | 200 | 171 | 8 | 41705bbba40eb5ddca0b223191aac1bce00163b8 | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-06 | 200 | 171 | 8 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_3|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.10e-06 | 200 | 171 | 8 | 53e04399d0308b40ae99fbfaa4ff62bf061822d8 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.10e-06 | 200 | 171 | 8 | cc8df398532c9324fd3e171000b1ea5c208cd691 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Basal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.10e-06 | 200 | 171 | 8 | 7098ae4b0ea8ba607519eaed8577c577530fc2a1 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_2|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.15e-06 | 153 | 171 | 7 | a44da11a913b19edde6c5d1d6e625c24b20ecbfd | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.15e-06 | 162 | 171 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.00e-06 | 168 | 171 | 7 | f150beee37e0252951a88adcd9e3f0a22e5cfdd9 | |
| ToppCell | Basal_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 4.00e-06 | 168 | 171 | 7 | 48089fa2d4a0f31a72405717119b767a92571f01 | |
| ToppCell | 15-Airway-Epithelial-Submucosal_gland_basal|Airway / Age, Tissue, Lineage and Cell class | 4.33e-06 | 170 | 171 | 7 | 61f8dd5e27df1b8d01ccfd0d25247b34aa8d182c | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.33e-06 | 170 | 171 | 7 | 6c65ddb496030bb479ef346cc37a9d4dfa6b824f | |
| ToppCell | facs-Heart-LV-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-06 | 171 | 171 | 7 | c6fc9ef9735dbf5314a4c7dac2b2954b0985ae4d | |
| ToppCell | facs-Heart-LV-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-06 | 171 | 171 | 7 | 55b194a9bf4d3e4b5d96e0d1298424359c441cbb | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.85e-06 | 173 | 171 | 7 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.04e-06 | 174 | 171 | 7 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 5.04e-06 | 174 | 171 | 7 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-06 | 177 | 171 | 7 | c6812679aa6522d03bd29144e71c5fae6a92325e | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-5|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.64e-06 | 177 | 171 | 7 | a0c7d08469c513cecf87777c19876884f1511570 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-06 | 177 | 171 | 7 | ff97398d2adb83063b7c53a264bfae86ea7ea304 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.64e-06 | 177 | 171 | 7 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-06 | 178 | 171 | 7 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 6.07e-06 | 179 | 171 | 7 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.07e-06 | 179 | 171 | 7 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.07e-06 | 179 | 171 | 7 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 6.07e-06 | 179 | 171 | 7 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 6.07e-06 | 179 | 171 | 7 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.53e-06 | 181 | 171 | 7 | 6b43dcaeeb02ad5900772b6f16f1581847050e38 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.53e-06 | 181 | 171 | 7 | f50561fdacfb83ba85fe6476e7cbc2bad1ebc826 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 6.53e-06 | 181 | 171 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 6.77e-06 | 182 | 171 | 7 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.02e-06 | 183 | 171 | 7 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-06 | 183 | 171 | 7 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-06 | 183 | 171 | 7 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 7.02e-06 | 183 | 171 | 7 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 7.27e-06 | 184 | 171 | 7 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.27e-06 | 184 | 171 | 7 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_proximal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.27e-06 | 184 | 171 | 7 | 575de705053da8b289670b5c40c1627c0833b5ed | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.27e-06 | 184 | 171 | 7 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 7.27e-06 | 184 | 171 | 7 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.27e-06 | 184 | 171 | 7 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | mild-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.27e-06 | 184 | 171 | 7 | 1a0e8b20b3ac8416d05c2d5934ab4ac80be4cce5 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.53e-06 | 185 | 171 | 7 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.53e-06 | 185 | 171 | 7 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-06 | 185 | 171 | 7 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.53e-06 | 185 | 171 | 7 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-06 | 185 | 171 | 7 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.53e-06 | 185 | 171 | 7 | e0172e0ab0f1d7151a3c3c63bb7c84d6bda92035 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-06 | 185 | 171 | 7 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | Control-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 7.53e-06 | 185 | 171 | 7 | d5d6d13e2f20b54ca55645b9a757b8599f4fd897 | |
| ToppCell | E15.5-Epithelial-airway_epithelial_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.80e-06 | 186 | 171 | 7 | bb2c7af3b1d8478c49a8626dbfd6c92c5e7adc4a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.80e-06 | 186 | 171 | 7 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | E15.5-Epithelial-airway_epithelial_cell-club_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.80e-06 | 186 | 171 | 7 | 86c809b99088d3d6c8f87785797c4beefdcddbe7 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.80e-06 | 186 | 171 | 7 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-06 | 187 | 171 | 7 | ef3c85c01bc3da408ae288b6e3096ad888a12e63 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.08e-06 | 187 | 171 | 7 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 8.08e-06 | 187 | 171 | 7 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 8.66e-06 | 189 | 171 | 7 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.96e-06 | 190 | 171 | 7 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| Computational | Genes in the cancer module 68. | 1.26e-04 | 26 | 109 | 4 | MODULE_68 | |
| Computational | Keratin. | 1.26e-04 | 26 | 109 | 4 | MODULE_298 | |
| Drug | olomoucine II | 1.55e-06 | 27 | 170 | 5 | CID005494414 | |
| Drug | Ricinine [524-40-3]; Down 200; 24.4uM; HL60; HT_HG-U133A | KANSL1L SIPA1L3 PER1 E2F4 RRBP1 TAF6L PLEKHM2 INF2 SPOCK3 CABIN1 | 1.99e-06 | 193 | 170 | 10 | 2505_DN |
| Drug | NSC34533 | 3.04e-06 | 54 | 170 | 6 | CID000003512 | |
| Disease | uterine fibroid | 1.73e-05 | 199 | 165 | 8 | EFO_0000731 | |
| Disease | Cutis Laxa, Autosomal Recessive, Type I | 3.11e-05 | 2 | 165 | 2 | C0268351 | |
| Disease | Cutis laxa, recessive, type I | 3.11e-05 | 2 | 165 | 2 | C0432336 | |
| Disease | Drug habituation | 4.75e-05 | 115 | 165 | 6 | C0013170 | |
| Disease | Drug abuse | 4.75e-05 | 115 | 165 | 6 | C0013146 | |
| Disease | Prescription Drug Abuse | 4.75e-05 | 115 | 165 | 6 | C4316881 | |
| Disease | Substance-Related Disorders | 4.75e-05 | 115 | 165 | 6 | C0236969 | |
| Disease | Drug Use Disorders | 4.75e-05 | 115 | 165 | 6 | C0013222 | |
| Disease | Drug Dependence | 4.75e-05 | 115 | 165 | 6 | C1510472 | |
| Disease | Substance Dependence | 4.75e-05 | 115 | 165 | 6 | C0038580 | |
| Disease | Substance Use Disorders | 4.75e-05 | 115 | 165 | 6 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 4.75e-05 | 115 | 165 | 6 | C0029231 | |
| Disease | Substance abuse problem | 4.98e-05 | 116 | 165 | 6 | C0740858 | |
| Disease | cutis laxa (implicated_via_orthology) | 9.29e-05 | 3 | 165 | 2 | DOID:3144 (implicated_via_orthology) | |
| Disease | keratoconjunctivitis (is_marker_for) | 9.29e-05 | 3 | 165 | 2 | DOID:9368 (is_marker_for) | |
| Disease | Glycogen storage disease | 1.10e-04 | 17 | 165 | 3 | cv:C0017919 | |
| Disease | mean reticulocyte volume | PDS5B DNAH2 E2F4 MAU2 PIGQ USP8 SPHK1 CHTF18 ATAD2B FBXO7 INTS4 HEATR3 VPS37D XPO7 | 1.70e-04 | 799 | 165 | 14 | EFO_0010701 |
| Disease | Iminoglycinuria | 1.85e-04 | 4 | 165 | 2 | C0268654 | |
| Disease | Squamous cell carcinoma of esophagus | 1.99e-04 | 95 | 165 | 5 | C0279626 | |
| Disease | Pachyonychia Congenita | 3.07e-04 | 5 | 165 | 2 | C0265334 | |
| Disease | Cutis laxa, autosomal recessive | 3.07e-04 | 5 | 165 | 2 | cv:C3665335 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 4.12e-04 | 239 | 165 | 7 | EFO_0010934 | |
| Disease | Glycogen Storage Disease | 4.55e-04 | 27 | 165 | 3 | C0017919 | |
| Disease | Cutis Laxa | 4.59e-04 | 6 | 165 | 2 | C0010495 | |
| Disease | cholangiocarcinoma (is_marker_for) | 4.61e-04 | 64 | 165 | 4 | DOID:4947 (is_marker_for) | |
| Disease | MYELODYSPLASTIC SYNDROME | 5.49e-04 | 67 | 165 | 4 | C3463824 | |
| Disease | Acute lymphocytic leukemia | 6.41e-04 | 7 | 165 | 2 | C0023449 | |
| Disease | Squamous cell carcinoma of lung | 7.56e-04 | 32 | 165 | 3 | C0149782 | |
| Disease | serum IgG glycosylation measurement | CDO1 CWF19L2 THSD7A EFCAB6 IFI44 NXPE1 PTPRR CADPS PHF14 C13orf42 | 7.59e-04 | 523 | 165 | 10 | EFO_0005193 |
| Disease | lactase-phlorizin hydrolase measurement | 8.51e-04 | 8 | 165 | 2 | EFO_0801753 | |
| Disease | Drug toxicity | 1.28e-03 | 84 | 165 | 4 | C0013221 | |
| Disease | Adverse reaction to drug | 1.28e-03 | 84 | 165 | 4 | C0041755 | |
| Disease | BRCA2 mutation carier statu | 1.36e-03 | 10 | 165 | 2 | EFO_0011022 | |
| Disease | dry eye syndrome (is_marker_for) | 1.36e-03 | 10 | 165 | 2 | DOID:10140 (is_marker_for) | |
| Disease | systolic blood pressure, self reported educational attainment | 1.36e-03 | 10 | 165 | 2 | EFO_0004784, EFO_0006335 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.50e-03 | 148 | 165 | 5 | C0279702 | |
| Disease | thrombin generation potential measurement | 1.65e-03 | 11 | 165 | 2 | EFO_0005538 | |
| Disease | Ashkenazi Jewish disorders | 1.65e-03 | 11 | 165 | 2 | cv:CN118946 | |
| Disease | Proteinuria | 1.80e-03 | 43 | 165 | 3 | C0033687 | |
| Disease | end stage renal disease (is_marker_for) | 2.18e-03 | 46 | 165 | 3 | DOID:783 (is_marker_for) | |
| Disease | Acute kidney injury | 2.53e-03 | 101 | 165 | 4 | C2609414 | |
| Disease | Acute Kidney Insufficiency | 2.53e-03 | 101 | 165 | 4 | C1565662 | |
| Disease | Kidney Failure, Acute | 2.53e-03 | 101 | 165 | 4 | C0022660 | |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 2.78e-03 | 50 | 165 | 3 | EFO_0010732 | |
| Disease | Hepatomegaly | 3.46e-03 | 54 | 165 | 3 | C0019209 | |
| Disease | Congenital total cataract | 3.54e-03 | 16 | 165 | 2 | C0266539 | |
| Disease | Keratoderma, Palmoplantar | 3.54e-03 | 16 | 165 | 2 | C4551675 | |
| Disease | Polyposis, Adenomatous Intestinal | 3.54e-03 | 16 | 165 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 3.54e-03 | 16 | 165 | 2 | C2713443 | |
| Disease | Respiratory Distress Syndrome, Adult | 3.64e-03 | 55 | 165 | 3 | C0035222 | |
| Disease | mean corpuscular hemoglobin concentration | PDS5B TTC28 MYO1B MYNN MAU2 PFKM PIGQ CHTF18 ATAD2B FBXO7 RIC8A HEATR3 VPS37D XPO7 | 3.77e-03 | 1105 | 165 | 14 | EFO_0004528 |
| Disease | renal fibrosis (implicated_via_orthology) | 4.00e-03 | 17 | 165 | 2 | DOID:0050855 (implicated_via_orthology) | |
| Disease | Adenomatous Polyposis Coli | 4.00e-03 | 17 | 165 | 2 | C0032580 | |
| Disease | reaction time measurement | 4.05e-03 | 658 | 165 | 10 | EFO_0008393 | |
| Disease | Malignant neoplasm of skin | 4.44e-03 | 59 | 165 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 4.44e-03 | 59 | 165 | 3 | C0037286 | |
| Disease | angiopoietin-related protein 1 measurement | 4.48e-03 | 18 | 165 | 2 | EFO_0801382 | |
| Disease | response to antipsychotic drug | 4.65e-03 | 60 | 165 | 3 | GO_0097332 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 4.99e-03 | 19 | 165 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 4.99e-03 | 19 | 165 | 2 | C2936783 | |
| Disease | Squamous cell carcinoma | 5.26e-03 | 124 | 165 | 4 | C0007137 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YSDCQELLNQLDQRF | 161 | Q8NDL9 | |
| DNDIRACINTLQFLY | 546 | Q8WVB6 | |
| AALSALCYIRSQLEN | 171 | Q8NCV1 | |
| EQLLNNLCARYDENL | 1121 | Q8NHU2 | |
| TAVLQEYSELERQLC | 221 | Q86X02 | |
| RADLAKYICENQDSI | 281 | P02768 | |
| QQRLVSELIACEQDY | 1086 | Q8TER5 | |
| LSCEERNLLSVAYKN | 36 | P31947 | |
| FNINDQSLIYTLTCR | 421 | Q6UX41 | |
| EKCQAYESNRESLLN | 146 | P43652 | |
| RKCNATQEYDINLLE | 591 | Q9NXL2 | |
| LSATQQSELRDVCDY | 56 | Q12774 | |
| YCTEQLAEVRQQSAE | 371 | Q7Z2Y8 | |
| RFTADELQILTYQLC | 771 | Q9UL18 | |
| LSATQQSELRDVCDY | 56 | A5YM69 | |
| RTQDCLQYLQELLAL | 81 | A0A1B0GVH6 | |
| YSLRDQLLVESCDNE | 706 | Q96DR7 | |
| ADEAQYCQLVRQLLD | 146 | O14874 | |
| DLCCQDNGRTLEVYQ | 371 | Q9BYV7 | |
| RLQNLRASCEALYSE | 776 | Q00975 | |
| YSSTQDQQLCAAELQ | 111 | Q9NZA1 | |
| NSRLLEDSNICNETY | 311 | Q9UBL0 | |
| SYLSICLEENNRFQV | 631 | Q96SN8 | |
| NTLLIYDNVNSCLLS | 1031 | Q9ULI1 | |
| RIFSQDSLCSQENYI | 296 | Q15032 | |
| DSLCSQENYIIDKRL | 301 | Q15032 | |
| LEQYQLCALAINDEC | 901 | Q9NTI5 | |
| RDELYIQLCRQTTEN | 781 | Q9C0H5 | |
| QACKLLSDDYEQVRS | 236 | Q96HW7 | |
| NCIRFYQTAEELNAS | 166 | Q9P2R3 | |
| IDQINRSLENYEPCS | 36 | Q8NBL1 | |
| CLEQAALVNYSRLSE | 841 | Q9ULU8 | |
| NGAETRVDLLCTYLQ | 13986 | Q8WXI7 | |
| SYLLCISENKENVRD | 366 | P20585 | |
| DLDEYTLRKNVAVNC | 351 | A0AUZ9 | |
| CQTDDIYNRNCLIEL | 1566 | Q14667 | |
| IRAETECQNTEYQQL | 421 | P13645 | |
| VYLEIDNRQCVQASS | 1676 | P46531 | |
| FVLQQDQRSCRAIDY | 286 | O95460 | |
| ALKECRNEYERSLQN | 446 | Q92805 | |
| YLLQVSDACAQEANL | 606 | Q7RTR2 | |
| VRQEIECQNQEYSLL | 426 | P35527 | |
| QSCILAQEEEQYLQS | 636 | Q7Z3F1 | |
| QLRDQAVEAQACYSL | 281 | Q86YR5 | |
| ICQINSERYLQLERA | 5921 | Q03001 | |
| YNKLCQEVTNRERND | 1106 | Q9BQS8 | |
| AVDQLERLYSLLSQC | 1416 | Q9ULI0 | |
| GEINTYRSLLENEDC | 391 | Q14532 | |
| LEQCTSNYREDLQAL | 616 | Q9ULE4 | |
| ENTVAETECRYALQL | 346 | P13646 | |
| ERLLYNCRNNTDLFE | 586 | Q8IVV2 | |
| YLSDSELNQLRLQGC | 3011 | Q9UPA5 | |
| QQINCLDSILRYLES | 626 | O15534 | |
| LDADISEQNRQVTCY | 2931 | Q9NYQ8 | |
| LRNEKCNENYTTDFI | 626 | P08237 | |
| AQNCQESRESDLVKY | 296 | Q2TBE0 | |
| DQDRALDYLSTCIDQ | 201 | P53618 | |
| LVSLNLNYNCISDEL | 226 | Q8N4B4 | |
| LNYNCISDELLENLC | 231 | Q8N4B4 | |
| RLEEFNTCYNSNQLE | 6 | Q86YV6 | |
| IELNQQTCLLTLRDY | 136 | Q9NPC7 | |
| LSLDLSYECQNEASL | 246 | P09848 | |
| CLENLTSLDVSYNLE | 1266 | Q5S007 | |
| LSDLVYLDCQNNRIR | 76 | Q8N7C0 | |
| LENSLAETECRYATQ | 346 | P19012 | |
| YSDTELQQCLAAAQA | 201 | Q9NQT4 | |
| CYAESIDDQLNTLLK | 181 | Q9NVV4 | |
| DYLIARCIDIQQSNE | 126 | Q6R327 | |
| VEYNKLCESLEELQN | 656 | O94880 | |
| RELADYLCEDAQQLS | 891 | Q27J81 | |
| ETRLYNKCQDLESLI | 81 | Q8IVE3 | |
| YQACDDIERLTQQQD | 611 | Q9NY74 | |
| SVNECDNYTIRNLVL | 521 | Q15256 | |
| LEANISCSLNELTYN | 321 | Q86YC2 | |
| NATALRLALQYSEQC | 441 | P23508 | |
| NEELSARYLSQCQEA | 651 | Q8TES7 | |
| RGNYSTDQLCVLDNV | 646 | Q7Z4Q2 | |
| AQNCTISIQDYEVFR | 136 | Q8TCB0 | |
| GNLAETENRYCVQLS | 326 | Q04695 | |
| CASNRLISTLENLYE | 771 | P54132 | |
| SLERCQSLEEIQRLY | 686 | Q9Y6J0 | |
| RNVTEDVQNSCLAYV | 126 | Q16254 | |
| NYSLDEIERNFCLQL | 281 | Q5THR3 | |
| LYQSADCSDANDALI | 186 | Q9Y3I1 | |
| SERVLRENQCAYIND | 121 | Q16878 | |
| LTYFLRCSELQENQL | 521 | Q9P278 | |
| EYVILNEDCQTSRAL | 96 | P51841 | |
| LQILCNSAENELRYE | 251 | Q5VVM6 | |
| LLYNACQLDNADEQA | 256 | Q86UW7 | |
| DTIFLREYQTRQDQC | 76 | P02763 | |
| EGIDDSVQLSRLCYN | 681 | Q8WYP5 | |
| GYILLDDNRSCQDIN | 276 | Q9UBX5 | |
| QGYQLLATRLCQDID | 271 | O95967 | |
| LDDCVIRQTNTQFQY | 1751 | Q9P225 | |
| SLLSELYCQENSVDA | 111 | Q9Y6X3 | |
| RDEAQTQYSQCLIEK | 386 | Q9BXL7 | |
| NENNYVLLENLECSA | 381 | Q6NVV3 | |
| CAENVNQDNLLSYAR | 326 | O94851 | |
| GLTLNSNAELCEYLD | 221 | Q8N323 | |
| TSELNFLLQEIDNCY | 151 | Q96RD6 | |
| LRIISDLQQSCEYDI | 236 | Q86X27 | |
| EYCVLEFSQDSQQLL | 931 | Q8IWE5 | |
| YTLTINDDQCLLLSE | 116 | P06865 | |
| LAEDVCYRLREATQN | 36 | Q9Y6J9 | |
| LDYSCSQDRDTQKIQ | 536 | Q93008 | |
| QQALRYLRSNCLDQV | 681 | Q9Y3M8 | |
| QRYDDCFSTNILTLI | 331 | Q695T7 | |
| TREVYCVQANENLLS | 461 | Q9UPZ6 | |
| ALQEQARTYLDLLCS | 4081 | Q8NF91 | |
| CANTLLYENRDLETR | 131 | Q69YZ2 | |
| FLQNLLSDERLCQSE | 601 | Q9H3E2 | |
| YALNSQLLRDLDSCN | 146 | A1L390 | |
| LRNDLAEYQRTCEDL | 246 | Q86SQ7 | |
| YLNSVCQSLLDNLDL | 521 | O95486 | |
| ETILQRCNLEEISNY | 336 | Q9NVN8 | |
| VLRQRVDSCSYDLDQ | 431 | Q9BRB3 | |
| RLINLLRQSQSYCTD | 21 | Q96QK8 | |
| RQEYLKDLAENCVSN | 821 | O60292 | |
| NVELCRDQAQYGLTD | 326 | Q9UIF3 | |
| DVNVNLYNLQDSCRR | 126 | Q9BSE5 | |
| SYLDRTEQLQAVLCS | 371 | Q9BV38 | |
| ELQQAYCELSRRISE | 331 | A8MXQ7 | |
| LASRLTLNCQNSYVE | 196 | Q9NZD8 | |
| DECLAVYRDLVRNSQ | 126 | O76094 | |
| RQSLQALACYADISV | 86 | Q9NPQ8 | |
| CSYTDLQLINAEEQT | 166 | Q8WXE9 | |
| TNDYEHCLDRNILSL | 316 | Q96N87 | |
| RNNEVEYCNQLLDSS | 1041 | Q8NFU7 | |
| EYQALTFLTRNEILC | 16 | A0PJX0 | |
| DIETRDCLQNTYNLN | 86 | Q8TCG1 | |
| NVNALELEDSALYLC | 96 | A0A5A2 | |
| ENVLCQTEYIFARSN | 256 | Q01973 | |
| YSCSREALQKLIDDQ | 131 | Q96JI7 | |
| VSQLDCLNRDNYIRS | 521 | Q04724 | |
| VCRQANEEYQILANS | 101 | Q13454 | |
| CLQEASQAYAQERQL | 176 | A2A3L6 | |
| QSTLQAECDQYRSIL | 1121 | Q9P2E9 | |
| NKDYLRLDQTDRECN | 106 | Q5GAN6 | |
| VNLALENACDEATYQ | 101 | P11217 | |
| NISQDALLTCRAEAY | 241 | Q9UPX0 | |
| LISECQRQQLEAVSY | 176 | Q5VYX0 | |
| AECELSRRQYAEQEL | 311 | Q9P246 | |
| RLVSVNEYCLDNTSL | 736 | Q8NI35 | |
| ANYQADLANITCEIA | 641 | Q7Z4S6 | |
| IDYINDSISDCQANI | 996 | Q7Z4S6 | |
| ERCESLVDIYSQLQQ | 226 | P42226 | |
| DYDQQVAISEALCRL | 226 | Q5T4T6 | |
| QYSLCQELCSELAQD | 431 | Q9UBT6 | |
| CEELIQQYNRAEDSI | 891 | Q7Z5K2 | |
| EEQSVQLLQCYLQED | 86 | Q5SRE5 | |
| ENYEESIAQLSRQCR | 1671 | Q9H254 | |
| ILDYSCSQDRDAQKI | 536 | O00507 | |
| QLEREACLASNYALA | 51 | Q86XT2 | |
| SQLCKDINNDYLAER | 306 | Q8TEA7 | |
| NVNALELDDSALYLC | 96 | A0A0C4DH59 | |
| SELRSIYLDKNEQCT | 271 | Q9BQ16 | |
| GNYEQAISCLERQLN | 971 | Q96AY4 | |
| LRSQDIQYNGSELSC | 206 | Q9NS68 | |
| QQLDQLSTIGRCEYE | 441 | Q9UIA9 | |
| LENCDLEESNSRDYL | 76 | Q8TAQ5 | |
| YEQVTNEDLLTNCTL | 126 | Q9NYA1 | |
| QDLCFNLYEVELSNR | 86 | Q5VWN6 | |
| LYFINCQSLLQDRDT | 121 | P19224 | |
| NEISRTEYLCENSLE | 656 | Q9HBM0 | |
| AILSETQFYEALRNC | 421 | Q8IWY8 | |
| VQELTYDLRSQCDAI | 336 | Q9BZH6 | |
| YISNSDLQRCVNLQA | 66 | O60603 | |
| NRNCYQDDINRSNLL | 806 | P40818 | |
| LTACLLQSELVNYER | 141 | Q8N6N2 | |
| SRQLEDILSTYCVDN | 76 | P40222 | |
| ANNIQELLYSASDIC | 596 | Q9P1Q0 | |
| LNALYTRFDQQCGEL | 506 | Q02108 | |
| LAELNQILYRCESEE | 901 | P35573 | |
| RENAYLTKDLTQDCL | 306 | Q96M32 | |
| AYRSLRDQDKDQCIL | 91 | O43795 | |
| CLNNFDLSEYRQILS | 1476 | Q9NQX4 |